Table 3 Sequelae risk.
From: Correlating COVID-19 severity with biomarker profiles and patient prognosis
Data | OR | 95% CI | P-value | |||
|---|---|---|---|---|---|---|
Low | High | |||||
(a) Musculoskeletal system | ||||||
Joint pain | Chronic lung disease | No | 1 | – | – | – |
Yes | 3.086 | 1.100 | 8.438 | 0.029 | ||
Diabetes mellitus | No | 1 | – | – | – | |
Yes | 3.789 | 1.429 | 9.998 | 0.007 | ||
Interleukin 6 | No | 1 | – | – | – | |
Yes | 2.335 | 1.069 | 5.068 | 0.032 | ||
Myalgia | Chronic lung disease | No | 1 | – | – | – |
Yes | 4.336 | 1.483 | 12.473 | 0.006 | ||
Diabetes mellitus | No | 1 | – | – | – | |
Yes | 3.428 | 1.175 | 9.793 | 0.022 | ||
(b) Cardiorespiratory system | ||||||
Dyspnea | Chronic lung disease | No | 1 | – | – | – |
Yes | 3.370 | 1.174 | 9.642 | 0.023 | ||
Clinical spectrum | Mild/moderate | 1 | – | – | – | |
Severe | 5.248 | 2.206 | 13.646 | < 0.001 | ||
Dry cough | Schooling | Graduated | 1 | – | – | – |
High and middle school | 3.385 | 1.354 | 8.968 | 0.010 | ||
Palpitations | Ethnic group | White | 1 | – | – | – |
Non-whites | 4.073 | 1.441 | 12.834 | 0.011 | ||
Chronic lung disease | No | 1 | – | – | – | |
Yes | 3.952 | 1.200 | 12.388 | 0.019 | ||
Dimer D | Low | 1 | – | – | – | |
High | 4.222 | 1.516 | 11.675 | 0.005 | ||
(c) Vascular system | ||||||
Phlebitis | Sex | Male | 1 | – | – | – |
Female | 3.872 | 1.347 | 13.973 | 0.020 | ||
Swelling | Physical activity | No | 1 | – | – | – |
Yes | 0.347 | 0.150 | 0.750 | 0.009 | ||
Cramp | Factor VIII | Low | 1 | – | – | – |
High | 4.426 | 1.656 | 12.372 | 0.003 | ||
